U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
8400184001The Incidence of Metabolic Syndrome Among Obese Children in Our RegionRecruitingNo Results AvailableMetabolic SyndromeOther: Routine laboratory testshttps://ClinicalTrials.gov/show/NCT01466556
8400284002Effect of Zydena (Udenafil) on Cerebral Blood Flow and Peripheral Blood ViscosityNot yet recruitingNo Results AvailableVascular Dementia|Subcortical Vascular DementiaDrug: Zydena (Udenafil)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01466543
8400384003Sublingual Misoprostol & Isoflurane During Caesarean SectionCompletedNo Results AvailablePregnancy|Cesarean DeliveryDrug: Placebo|Drug: Misoprostolhttps://ClinicalTrials.gov/show/NCT01466530
8400484004A Relative BioavailabilityStudy Of Ibuprofen 40mg/ml (laboratórios Pfizer Ltda) In The Oral Suspension Form.CompletedNo Results AvailableHealthyDrug: Alivium®|Drug: Ibuprofenhttps://ClinicalTrials.gov/show/NCT01466517
8400584005Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human SkinTerminatedNo Results AvailableRenal Cell Carcinoma|Hepatocellular Carcinoma|Colorectal CarcinomaProcedure: skin punch biopsyhttps://ClinicalTrials.gov/show/NCT01466504
8400684006Refining Paracervical Block Techniques for Pain Control in First Trimester Surgical AbortionRecruitingNo Results AvailablePainDrug: Paracervical block technique with lidocainehttps://ClinicalTrials.gov/show/NCT01466491
8400784007An Exploratory Psoriasis Plaque Test Study With LEO 29102 Plus Calcipotriol, Ointment, in Psoriasis VulgarisCompletedNo Results AvailablePsoriasis VulgarisDrug: Ointment A: LEO 29102 2.5 mg/g plus calcipotriol 50 µg/g ointment|Drug: Ointment B: LEO 29102 2.5 mg/g ointment|Drug: Ointment C: Calcipotriol 50 µg/g ointment|Drug: Ointment D: LEO 29102 2.5 mg/g plus calcipotriol 50 µg/g ointment|Drug: Ointment G: LEO 29102 2.5 mg/g plus calcipotriol 50 µg/g ointment|Drug: Daivonex® ointment|Drug: Diprosone® ointmenthttps://ClinicalTrials.gov/show/NCT01466478
8400884008Vitamin D and Grass Pollen Specific ImmunotherapyCompletedNo Results AvailableAllergic RhinoconjunctivitisDrug: Cholecalciferol|Other: middle-chain fatty acids (carrier)https://ClinicalTrials.gov/show/NCT01466465
8400984009Antiplatelet Effect of Low Doses of Aspirin Taken Every 12 Hours in Patients Undergoing Coronary Artery Bypass Graft and/or Aortic Valve SurgeryRecruitingNo Results AvailableCoronary ArteriosclerosisDrug: Aspirin|Drug: Aspirin|Drug: Aspirinhttps://ClinicalTrials.gov/show/NCT01466452
8401084010Repetitive Transcranial Magnetic Stimulation (rTMS) and P50 Evoked Potential ComponentCompletedNo Results AvailableDepression|SchizophreniaProcedure: high-frequency of repetitive transcranial magnetic stimulation (rTMS)|Procedure: low frequency of repetitive transcranial magnetic stimulation (rTMS)https://ClinicalTrials.gov/show/NCT01466439
8401184011The Role of FDG-PET/CT Imaging in the Management of Patients With Thromboembolic Disorders (The PETVET Study)CompletedNo Results AvailableVenous Thromboembolic Diseasehttps://ClinicalTrials.gov/show/NCT01466426
8401284012Two Formulations of ELAPR Compared to Restylane® Vital Light Following Repeat Implants in the Upper Arm DermisCompletedNo Results AvailableIntrinsic Aging of SkinDevice: Tropoelastinhttps://ClinicalTrials.gov/show/NCT01466413
8401384013Fermentation Rate of Infant FormulaCompletedNo Results AvailableHealthyhttps://ClinicalTrials.gov/show/NCT01466400
8401484014A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in AdultsCompletedHas ResultsMeningococcal Disease|Meningococcal Meningitis|Typhoid|Yellow Fever|Rabies|Japanese EncephalitisBiological: Typhoid Vi Polysaccharide Vaccine|Biological: Yellow Fever Vaccine|Biological: Japanese Encephalitis Vaccine|Biological: Rabies Vaccine|Biological: MenACWY-CRM Vaccinehttps://ClinicalTrials.gov/show/NCT01466387
8401584015Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's DiseaseCompletedNo Results AvailableCrohn's DiseaseDrug: Placebo|Drug: Placebo|Drug: BMS-936557 (Anti-IP-10 Antibody)|Drug: BMS-936557 (Anti-IP-10 Antibody)|Drug: BMS-936557 (Anti-IP-10 Antibody)|Drug: BMS-936557 (Anti-IP-10 Antibody)|Drug: BMS-936557 (Anti-IP-10 Antibody)https://ClinicalTrials.gov/show/NCT01466374
8401684016Evaluation of the Nicotine Lozenge in Relief of Provoked Acute CravingCompletedHas ResultsSmoking|Smoking CessationDrug: Nicotine lower dose|Drug: Nicotine higher dose|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01466361
8401784017Effects of a Common Cold Treatment on Cognitive FunctionCompletedHas ResultsCommon ColdDrug: Paracetamol and Caffeine|Drug: Paracetamolhttps://ClinicalTrials.gov/show/NCT01466348
8401884018An Adaptive Phase I Study to Evaluate the Safety, Efficacy and Dose Responses of Ronacaleret in Healthy Human VolunteersCompletedNo Results AvailableBone Marrow TransplantationDrug: Ronacaleret (100mg tablet)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01466335
8401984019A Study to Assess the Relative Bioavailability of Different Formulations of GSK2018682, a Sphingosine-1-phosphate Receptor Subtype 1 Agonist, in Healthy Volunteers.CompletedNo Results AvailableMultiple Sclerosis, Relapsing-RemittingDrug: GSK2018682 CD2 Capsule; GSK2018682 CD3 non-micronised Tablet; GSK2018682 CD3 micronised Tablet; GSK2018682 CD3 non-micronised Tablet in fed statehttps://ClinicalTrials.gov/show/NCT01466322
8402084020Efficacy of Adjustable Thermoplastic Oral Appliances in Patient With OSAEnrolling by invitationNo Results AvailableOSA|ComplicationDevice: Somnoguard oral applianceshttps://ClinicalTrials.gov/show/NCT01466309
8402184021The Middle East "Stepping Forward" Project (MESF)RecruitingNo Results AvailableCerebral Palsy|Poststroke/CVA ParesisDevice: Chaotic Perturbation|Device: Dummy not active shoes|Device: Treadmill traininghttps://ClinicalTrials.gov/show/NCT01466296
8402284022Biomarkers in Patients With RhabdomyosarcomaActive, not recruitingNo Results AvailableSarcomaGenetic: DNA methylation analysis|Genetic: fluorescence in situ hybridization|Genetic: gene expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01466283
8402384023Study of Donepezil in Female Breast Cancer Survivors With Cognitive DysfunctionCompletedHas ResultsAnxiety Disorder|Breast Cancer|Cognition Disorders|Depression|Fatigue|Sleep DisordersDrug: donepezil hydrochloride|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01466270
8402484024Biomarkers in Patients With Head and Neck CancerNot yet recruitingNo Results AvailableHead and Neck CancerBiological: cetuximab|Drug: cisplatin|Genetic: DNA analysis|Genetic: gene expression analysis|Genetic: mutation analysis|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01466257
8402584025Biomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397Not yet recruitingNo Results AvailableHead and Neck CancerBiological: cetuximab|Drug: cisplatin|Genetic: gene expression analysis|Genetic: microarray analysis|Other: immunohistochemistry staining method|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01466244
8402684026Everolimus in Refractory Testicular Germ Cell CancerRecruitingNo Results AvailableGerm Cell TumorDrug: Everolimushttps://ClinicalTrials.gov/show/NCT01466231
8402784027World Trade Center (WTC) CHESTCompletedNo Results AvailablePulmonary Disease|Cardiac Disease|Cardiopulmonary Disease|Obstructive Sleep Apnea|Cardiovascular Diseasehttps://ClinicalTrials.gov/show/NCT01466218
8402884028Clinical Testing of a D1 Agonist for Cognitive Enhancement in Schizotypal Personality DisorderRecruitingNo Results AvailableCognitive Impairments|Schizotypal Personality DisorderDrug: DAR-0100A|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01466205
8402984029Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Relapser Genotype 2 Hepatitis C Infected PatientsCompletedHas ResultsChronic Hepatitis CDrug: MP-424 (generic name:Telaprevir)|Drug: Ribavirin|Drug: Peginterferon alfa-2bhttps://ClinicalTrials.gov/show/NCT01466192
8403084030Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)Active, not recruitingHas ResultsAcute Lymphoblastic LeukemiaBiological: Blinatumomabhttps://ClinicalTrials.gov/show/NCT01466179

* Görseller ve İçerik tekif hakkına sahip olabilir